Investigation Report on China Deproteinized Calf Blood Extract Market [2010-2019]

1
Investigation Report on China Deproteinized Calf
Blood Extract Market 2010-2019
Market Reports On China
http//www.marketreportsonchina.com
2
Summary
As a drug improving energy metabolism,
deproteinized calf blood extract has received
wide attention due to its efficacy in nervous
system. Currently, it is mainly used to treat
brain disease, nervous system disease, vascular
disease, ulcer, burn, radiation injury and eye
disease. Developed by Jaeger KH with membrane
filtering technology, deproteinized calf blood
extract is the deproteinized blood extract of
new-born calf with a relative molecular mass of
less than 6000 dalton. Since the 1960s,
deproteinized calf blood extract has been
marketed all over the world. Recently, nervous
system drug has reported a stable growth. Among
the TOP500 drugs in the seven big markets,
nervous system drug reported a sales value of USD
43.286 billion with a year-on-year growth of 3
in 2013. Brain system drug, in particular, has
undergone a downturn in global market.
Scope The report provides in-depth market
analysis, information and insights, including
? A detailed coverage of the travel and
tourism industry in China ? A comprehensive
analysis of the airlines market in China ?
Profile of the top airlines operating in China

3
However, as people become increasingly aware of
the pathogenesis and clinical pharmacology of
neurologic diseases, the market of neurologic
drug has grown fast in China. As a leading
neurologic drug, deproteinized calf blood extract
has reported a large sales in China. By the end
of Aug.2015, there are 18 manufacturers of
deproteinized calf blood extract and
deproteinized calf blood extract injection, 3
manufactures of deproteinized calf blood extract
ophthalmic gel and 1 manufacturer of
deproteinized calf blood extract
capsule. According to market survey, the sales
value of deproteinized calf blood extract in
sample hospitals reached about CNY 1.2 billion
and CAGR during the period of 2005-2014 surpassed
30. Jinzhou Ahon Pharmaceutical Co., Ltd,
Heilongjiang Jiangshi Pharmaceutical Co., Ltd,
Harbin Sanctity Pharmaceutical Co., Ltd, Jilin
Connell Pharmaceutical Co., Ltd and Wuhan
Humanwell Pharmaceutical Co., Ltd occupy the
market, among which Jinzhou Ahon Pharmaceutical
Co., Ltd had the largest market share of about
71 for sales value in 2014.

4
The market size of deproteinized calf blood
extract in China is expected to keep growing in
next few years. Readers can get at least the
following information through this
report -market size of deproteinized calf blood
extract in China -competitive landscape of
deproteinized calf blood extract market in
China -price of deproteinized calf blood extract
made by different enterprises in China -market
outlook of deproteinized calf blood extract in
China

5
The author suggests the following groups of
people purchase this report -drug
makers -investors/research institutions
interested in Chinese medicine market -any
interest in Chinese medicine market, please
contact for customized survey service

6
Table Of Content
1 Related Concepts of Deproteinized Calf Blood
Extract 2 Market Profile of Deproteinized Calf
Blood Extract in China 3 Survey on the Sales of
Deproteinized Calf Blood Extract in China,
2010-2014 4 Survey on Market Share of Major
Manufacturers of Deproteinized Calf Blood Extract
in China, 2010-2014 5 Survey on Dosage Forms of
Deproteinized Calf Blood Extract in China,
2010-2014 6 Reference Price of Deproteinized
Calf Blood Extract in Chinese Hospitals in
2014

7
To view the full Executive Summary and Table of
Contents, please visit Investigation Report
on China Deproteinized Calf Blood Extract Market
2010-2019 Contact Us Market Reports On
ChinaContact No 91 2227810772, 27810773
Email id info_at_marketreportsonchina.com
Website http//marketreportsonchina.com/